LONDON — A child woman born with profound genetic deafness can now hear unaided after receiving a “groundbreaking” gene remedy trial, Britain’s Nationwide Well being Service stated Thursday.
Opal Sandy, an 18-month-old from Oxfordshire, England, is the primary affected person handled in a worldwide gene remedy trial that’s exhibiting “mind-blowing” outcomes, Addenbrooke’s Hospital in Cambridge stated in a assertion. Opal is “the primary British affected person on the earth and the youngest youngster to obtain the sort of therapy,” the hospital stated.
